{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T21:56:36Z","timestamp":1769550996602,"version":"3.49.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,27]]},"DOI":"10.7759\/cureus.36734","type":"journal-article","created":{"date-parts":[[2023,3,27]],"date-time":"2023-03-27T11:45:55Z","timestamp":1679917555000},"source":"Crossref","is-referenced-by-count":5,"title":["Is Serum Ferritin an Early Marker for COVID-19-Associated Mucormycosis?"],"prefix":"10.7759","author":[{"given":"Indu","family":"DP","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kala","family":"Yadhav ML","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chetana","family":"GS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/10408363.2020.1783198","article-title":"The COVID-19 pandemic","volume":"57","author":"Ciotti M","year":"2020","unstructured":"Ciotti M, Ciccozzi M, Terrinoni A, Jiang WC, Wang CB, Bernardini S. The COVID-19 pandemic. Crit Rev Clin Lab Sci. 2020, 57:365-88. 10.1080\/10408363.2020.1783198","journal-title":"Crit Rev Clin Lab Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01441","article-title":"Immune response, inflammation, and the clinical spectrum of COVID-19","volume":"11","author":"Garc\u00eda LF","year":"2020","unstructured":"Garc\u00eda LF. Immune response, inflammation, and the clinical spectrum of COVID-19. Front Immunol. 2020, 11:1441. 10.3389\/fimmu.2020.01441","journal-title":"Front Immunol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s11046-020-00462-9","article-title":"Fungal co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China","volume":"185","author":"Song G","year":"2020","unstructured":"Song G, Liang G, Liu W. Fungal co-infections associated with global COVID-19 pandemic: a clinical and diagnostic perspective from China. Mycopathologia. 2020, 185:599-606. 10.1007\/s11046-020-00462-9","journal-title":"Mycopathologia"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13335","article-title":"ECMM\/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries","volume":"64","author":"Rudramurthy SM","year":"2021","unstructured":"Rudramurthy SM, Hoenigl M, Meis JF, et al.. ECMM\/ISHAM recommendations for clinical management of COVID-19 associated mucormycosis in low- and middle-income countries. Mycoses. 2021, 64:1028-37. 10.1111\/myc.13335","journal-title":"Mycoses"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab726","article-title":"Coronavirus disease 2019-associated mucormycosis: risk factors and mechanisms of disease","volume":"74","author":"Narayanan S","year":"2022","unstructured":"Narayanan S, Chua JV, Baddley JW. Coronavirus disease 2019-associated mucormycosis: risk factors and mechanisms of disease. Clin Infect Dis. 2022, 74:1279-83. 10.1093\/cid\/ciab726","journal-title":"Clin Infect Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and clinical manifestations of mucormycosis","volume":"54 Suppl 1","author":"Petrikkos G","year":"2012","unstructured":"Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012, 54 Suppl 1:S23-34. 10.1093\/cid\/cir866","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/myc.13338","article-title":"COVID-19-associated mucormycosis: an updated systematic review of literature","volume":"64","author":"Pal R","year":"2021","unstructured":"Pal R, Singh B, Bhadada SK, Banerjee M, Bhogal RS, Hage N, Kumar A. COVID-19-associated mucormycosis: an updated systematic review of literature. Mycoses. 2021, 64:1452-9. 10.1111\/myc.13338","journal-title":"Mycoses"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3390\/jof5010023","article-title":"Disease entities in mucormycosis","volume":"5","author":"Serris A","year":"2019","unstructured":"Serris A, Danion F, Lanternier F. Disease entities in mucormycosis. J Fungi (Basel). 2019, 5:23. 10.3390\/jof5010023","journal-title":"J Fungi (Basel)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2009.02976.x","article-title":"The role of iron and iron chelators in zygomycosis","volume":"15 Suppl 5","author":"Symeonidis AS","year":"2009","unstructured":"Symeonidis AS. The role of iron and iron chelators in zygomycosis. Clin Microbiol Infect. 2009, 15 Suppl 5:26-32. 10.1111\/j.1469-0691.2009.02976.x","journal-title":"Clin Microbiol Infect"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e3283165fd1","article-title":"Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment","volume":"21","author":"Ibrahim AS","year":"2008","unstructured":"Ibrahim AS, Spellberg B, Edwards J Jr. Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment. Curr Opin Infect Dis. 2008, 21:620-5. 10.1097\/QCO.0b013e3283165fd1","journal-title":"Curr Opin Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/0268-960x(90)90006-e","article-title":"Ferritin","volume":"4","author":"Worwood M","year":"1990","unstructured":"Worwood M. Ferritin. Blood Rev. 1990, 4:259-69. 10.1016\/0268-960x(90)90006-e","journal-title":"Blood Rev"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2020.06.053","article-title":"Serum ferritin as an independent risk factor for severity in COVID-19 patients","volume":"81","author":"Lin Z","year":"2020","unstructured":"Lin Z, Long F, Yang Y, Chen X, Xu L, Yang M. Serum ferritin as an independent risk factor for severity in COVID-19 patients. J Infect. 2020, 81:647-79. 10.1016\/j.jinf.2020.06.053","journal-title":"J Infect"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s12663-021-01604-2","article-title":"Current understanding in the pathophysiology of SARS-CoV-2-associated rhino-orbito-cerebral mucormycosis: a comprehensive review","volume":"20","author":"Jose A","year":"2021","unstructured":"Jose A, Singh S, Roychoudhury A, Kholakiya Y, Arya S, Roychoudhury S. Current understanding in the pathophysiology of SARS-CoV-2-associated rhino-orbito-cerebral mucormycosis: a comprehensive review. J Maxillofac Oral Surg. 2021, 20:373-80. 10.1007\/s12663-021-01604-2","journal-title":"J Maxillofac Oral Surg"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2022\/52844.15908","article-title":"Estimation of ferritin and D-dimer levels in COVID-19 patients with mucormycosis: a cross-sectional study","volume":"16","author":"Yesupatham ST","year":"2022","unstructured":"Yesupatham ST, Mohiyuddin SA, Arokiyaswamy S, Brindha HS, Anirudh PB. Estimation of ferritin and D-dimer levels in COVID-19 patients with mucormycosis: a cross-sectional study. J Clin Diagn Res. 2022, 16:12-5. 10.7860\/JCDR\/2022\/52844.15908","journal-title":"J Clin Diagn Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s12070-021-02970-6","article-title":"Role of COVID 19 inflammatory markers in rhino-orbito-cerebral mucormycosis: a case study in predisposed patients at a designated nodal centre","volume":"74","author":"Goddanti N","year":"2022","unstructured":"Goddanti N, Reddy YM, Kumar MK, Rajesh M, Reddy LS. Role of COVID 19 inflammatory markers in rhino-orbito-cerebral mucormycosis: a case study in predisposed patients at a designated nodal centre. Indian J Otolaryngol Head Neck Surg. 2022, 74:3498-504. 10.1007\/s12070-021-02970-6","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.20569","article-title":"Hyperferritinemia and the extent of mucormycosis in COVID-19 patients","volume":"13","author":"Bhadania S","year":"2021","unstructured":"Bhadania S, Bhalodiya N, Sethi Y, et al.. Hyperferritinemia and the extent of mucormycosis in COVID-19 patients. Cureus. 2021, 13:e20569. 10.7759\/cureus.20569","journal-title":"Cureus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/jof7040298","article-title":"When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis","volume":"7","author":"John TM","year":"2021","unstructured":"John TM, Jacob CN, Kontoyiannis DP. When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis. J Fungi (Basel). 2021, 7:298. 10.3390\/jof7040298","journal-title":"J Fungi (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s40475-020-00222-1","article-title":"Host-pathogen molecular factors contribute to the pathogenesis of Rhizopus spp. in diabetes mellitus","volume":"8","author":"Morales-Franco B","year":"2021","unstructured":"Morales-Franco B, Nava-Villalba M, Medina-Guerrero EO, S\u00e1nchez-Nu\u00f1o YA, Davila-Villa P, Anaya-Ambriz EJ, Charles-Ni\u00f1o CL. Host-pathogen molecular factors contribute to the pathogenesis of Rhizopus spp. in diabetes mellitus. Curr Trop Med Rep. 2021, 8:6-17. 10.1007\/s40475-020-00222-1","journal-title":"Curr Trop Med Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/mmy\/myac072.P430","article-title":"P430 Correlation of microscopy and culture findings with serum ferritin level for the diagnosis of rhino-orbito-cerebral mucormycosis during COVID-19 pandemic\u2014a study from tertiary care hospital India","volume":"60","author":"Lakshmanan J","year":"2022","unstructured":"Lakshmanan J, Das S, Singh NP. P430 Correlation of microscopy and culture findings with serum ferritin level for the diagnosis of rhino-orbito-cerebral mucormycosis during COVID-19 pandemic\u2014a study from tertiary care hospital India. Med Mycol. 2022, 60:myac072P430. 10.1093\/mmy\/myac072.P430","journal-title":"Med Mycol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir865","article-title":"Pathogenesis of mucormycosis","volume":"54 Suppl 1","author":"Ibrahim AS","year":"2012","unstructured":"Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of mucormycosis. Clin Infect Dis. 2012, 54 Suppl 1:S16-22. 10.1093\/cid\/cir865","journal-title":"Clin Infect Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/125908-is-serum-ferritin-an-early-marker-for-covid-19-associated-mucormycosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:58:32Z","timestamp":1707508712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/125908-is-serum-ferritin-an-early-marker-for-covid-19-associated-mucormycosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,27]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.36734","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,27]]}}}